Physician profile
Bryan Bertoglio
NPI 1588871388
$16,392.01
in general payments reported to CMS, 2019-2025
15 companies · $1,681 in 2025
The $1,681 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $47.50 · 2021: $36.21 · 2022: $23.42 · 2023: $1,798 · 2024: $137 · 2025: $1,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,075 · Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,075.00 |
| Food and Beverage | $541.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nanohive Medical LLC | $10,941.97 | 2019 | |
| Augmedics INC. | $3,270.58 | 2023-2025 | Xvision |
| Medical Device Business Services, INC. | $900.00 | 2019 | |
| Corelink, LLC | $344.34 | 2019 | |
| Depuy Synthes Sales INC. | $219.31 | 2019-2024 | Teligen, Conduit, Concorde |
| Nuvasive, INC. | $212.38 | 2019 | |
| Aesculap, INC. | $137.34 | 2022-2025 | M.Blue |
| Medtronic USA, INC. | $127.05 | 2019 | |
| Neuropace, INC. | $86.62 | 2024 | |
| Alphatec Spine, INC | $36.21 | 2021 | |
| Medtronic, INC. | $34.26 | 2023-2025 | Catalyft Pl Expandable Interbody System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Cerapedics INC. | $33.39 | 2020 | |
| Abbott Laboratories | $19.50 | 2019 | |
| Orthofix Medical, INC. | $14.95 | 2025 | Cervical-Stim, Spinal-Stim |
| Surgalign Spine Technologies, INC. | $14.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,488,633.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Bertoglio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.